MHT: Funding drugs for rare diseases

(NECN) - When it comes to the companies that produce pricey drugs for rare diseases, one might think it would difficult to find funding in this recession. But some venture capital firms are specifically targeting such investments. Reporter Julie Donnelly shares the details on this story from the BBJ-Mass High Tech newsroom.

NECN | October 30, 2009

Tags:. .bbj. .necn. .pricey. .newsroom. .donnelly